Article
DNA stabilization by the upregulation of estrogen signaling in BRCA gene mutation carriers.
Drug design, development and therapy - 1 Jan 2015
Suba Zsuzsanna
Abstract excerpt
Currently available scientific evidence erroneously suggests that mutagenic weakness or loss of the BRCA1/2 genes may liberate the proliferative effects of estrogen signaling, which provokes DNA damage and genomic instability. Conversely, BRCA mutation seems to be an imbalanced defect, crudely inhibiting the upregulation of estrogen receptor expression and liganded transcriptional activity, whereas estrogen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
